Literature DB >> 24010842

O-antigens of bacteria of the genus providencia: structure, serology, genetics, and biosynthesis.

O G Ovchinnikova1, A Rozalski, B Liu, Y A Knirel.   

Abstract

The genus Providencia consists of eight species of opportunistic pathogenic enterobacteria that can cause enteric diseases and urinary tract infections. The existing combined serological classification scheme of three species, P. alcalifaciens, P. stuartii, and P. rustigianii, is based on the specificity of O-antigens (O-polysaccharides) and comprises 63 O-serogroups. Differences between serogroups are related to polymorphism at a specific genome locus, the O-antigen gene cluster, responsible for O-antigen biosynthesis. This review presents data on structures of 36 O-antigens of Providencia, many of which contain unusual monosaccharides and non-carbohydrate components. The structural data correlate with the immunospecificity of the O-antigens and enable substantiation on a molecular level of serological relationships within the genus Providencia and between strains of Providencia and bacteria of the genera Proteus, Escherichia, and Salmonella. Peculiar features of the O-antigen gene cluster organization in 10 Providencia serogroups and biosynthetic pathways of nucleotide precursors of specific monosaccharide components of the O-antigens also are discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24010842     DOI: 10.1134/S0006297913070110

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  9 in total

1.  A Tailspike with Exopolysaccharide Depolymerase Activity from a New Providencia stuartii Phage Makes Multidrug-Resistant Bacteria Susceptible to Serum-Mediated Killing.

Authors:  Hugo Oliveira; Graça Pinto; Bruna Mendes; Oscar Dias; Hanne Hendrix; Ergun Akturk; Jean-Paul Noben; Jan Gawor; Małgorzata Łobocka; Rob Lavigne; Joana Azeredo
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

2.  Molecular structure of an N-formyltransferase from Providencia alcalifaciens O30.

Authors:  Nicholas A Genthe; James B Thoden; Matthew M Benning; Hazel M Holden
Journal:  Protein Sci       Date:  2015-04-02       Impact factor: 6.725

3.  A case of bilateral keratitis caused by Providencia alcalifaciens: a rarely encountered ocular pathogen.

Authors:  Won Choi; Yong Sok Ji; Kyung Chul Yoon
Journal:  Int Ophthalmol       Date:  2017-05-17       Impact factor: 2.031

4.  Septicemia in an Indian Rhesus Macaque (Macaca mulatta) associated with Providencia stuartii.

Authors:  David X Liu; Peter J Didier; Gail Plauche; Bapi Pahar
Journal:  J Med Primatol       Date:  2016-07-28       Impact factor: 0.667

5.  Large Sequence Diversity within the Biosynthesis Locus and Common Biochemical Features of Campylobacter coli Lipooligosaccharides.

Authors:  Alejandra Culebro; Joana Revez; Ben Pascoe; Yasmin Friedmann; Matthew D Hitchings; Jacek Stupak; Samuel K Sheppard; Jianjun Li; Mirko Rossi
Journal:  J Bacteriol       Date:  2016-09-22       Impact factor: 3.490

6.  Horizontal transfers and gene losses in the phospholipid pathway of bartonella reveal clues about early ecological niches.

Authors:  Qiyun Zhu; Michael Kosoy; Kevin J Olival; Katharina Dittmar
Journal:  Genome Biol Evol       Date:  2014-08-08       Impact factor: 3.416

7.  Clinical and drug resistance characteristics of Providencia stuartii infections in 76 patients.

Authors:  Jiachang Liu; Ruikai Wang; Ming Fang
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

8.  Total synthesis of the O-antigen repeating unit of Providencia stuartii O49 serotype through linear and one-pot assemblies.

Authors:  Tanmoy Halder; Somnath Yadav
Journal:  Beilstein J Org Chem       Date:  2021-12-13       Impact factor: 2.883

9.  Structure of the 4-O-[1-Carboxyethyl]-d-Mannose-Containing O-Specific Polysaccharide of a Halophilic Bacterium Salinivibrio sp. EG9S8QL.

Authors:  Elena N Sigida; Ibrahim M Ibrahim; Maxim S Kokoulin; Hussein H Abulreesh; Khaled Elbanna; Svetlana A Konnova; Yulia P Fedonenko
Journal:  Mar Drugs       Date:  2021-09-07       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.